Press Releases

Dubai, June 26, 2026 (GLOBE NEWSWIRE) -- Reference is made to the stock exchange announcement released 23 June 2026 by Vantage Drilling International Ltd. (the "Company"), regarding the intention to repurchase own shares prior to completion of a merger pursuant to which a wholly owned subsidiary of Eldorado Drilling AS is to merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Eldorado Drilling AS (the "Merger").

Toll Brothers at Saddleback brings modern single-story homes and resort-style amenities to premier master-planned community

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Blaize Holdings, Inc. (NASDAQ: BZAI) resulting from allegations that Blaize may have issued materially misleading business information to the investing public.

EATONTOWN, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, today announced that the Company’s Board of Directors (the “Board”) has elected Peter Bell to the Board. With the election of Mr. Bell, Climb’s Board increased to five total members, four of whom are independent under the Nasdaq listing standards. Mr. Bell will serve as the Chair of the Nominating and Corporate Governance Committee.

NEW YORK, 25 juin 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome pour développer des thérapies cellulaires et géniques, a tenu son assemblée générale mixte ce jour à 14h30, heure de Paris, à l’auditorium du site Biopark, situé au 11 rue Watt, 4^ème étage, 75013 Paris, France.

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, held today its shareholders general meeting at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4^th floor, 75013 Paris, France.

Bridging the Gap Between Making Money and Actually Building Wealth

Dubai, June 26, 2026 (GLOBE NEWSWIRE) -- Reference is made to the announcement by Vantage Drilling International Ltd. (the “Company”) on 29 May 2026 regarding the proposed merger pursuant to which a wholly owned subsidiary of Eldorado Drilling AS is to merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Eldorado Drilling AS (the "Merger"). The Company is pleased to announce that all conditions to completion of the Merger are expected to be satisfied as of 1:00 PM ET on 26 June 2026, subject to continued satisfaction of customary closing conditions through to that time.

FDA-registered manufacturer examines growing use of high-concentration niacinamide formulas and reports that ingredient balance may play a greater role in product performance than active percentage alone.